tibolone has been researched along with Body Weight in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Almanza-Pérez, JC; Bautista-Poblet, G; Coyoy-Salgado, A; Estrada-Cruz, NA; Fortis-Barrera, Á; Guerra-Araiza, C; Manuel-Apolinar, L; Orozco-Suárez, S; Segura-Uribe, JJ | 1 |
| Câmara, NR; de Carvalho, AC; Guzmán-Silva, MA; Henriques, HN; Pantaleão, JA | 1 |
| Blake, GM; Fogelman, I; Patel, R; Rajamanohara, R; Robinson, J; Rymer, J | 1 |
| Anthony, MS; Clarkson, TB; Rankin, SE; Shadoan, MK; Wagner, JD | 1 |
| Byrne, D; Damjanovic, T; Dimkovic, N; Mikhailidis, DP; Ostberg, JE; Prelevic, GM | 1 |
| Bilgin, O; Gol, M; Ozsener, S; Oztekin, K; Sendag, F; Tanyalcin, T; Uretmen, S | 1 |
| Boyanov, MA; Shinkov, AD | 1 |
| Crona, N; Enk, L; Samsioe, G; Silfverstolpe, G | 1 |
| Coope, J | 1 |
| Genazzani, AD | 1 |
| Ederveen, AG; Kloosterboer, HJ | 1 |
| Basurto, L; Fonseca, E; Galván, R; Ochoa, R; Zárate, A | 1 |
| Katsikis, IK; Kourtis, AI; Mavromatidis, GA; Panidis, DK; Rousso, DH; Stergiopoulos, KN | 1 |
| Baylink, DJ; Freeman, R; Gallagher, JC; McClung, M | 1 |
| Anthony, MS; Clarkson, TB; Wagner, JD | 1 |
5 trial(s) available for tibolone and Body Weight
| Article | Year |
|---|---|
The effect of weight and weight change on the long-term precision of spine and hip DXA measurements.
Topics: Absorptiometry, Photon; Aged; Body Mass Index; Body Weight; Bone Density; Estrogen Receptor Modulators; Female; Femur Neck; Follow-Up Studies; Hip Joint; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Phantoms, Imaging; Retrospective Studies; Weight Gain | 2011 |
Effect of tibolone on markers of cardiovascular disease risk in postmenopausal women undergoing hemodialysis: a pilot study.
Topics: Antihypertensive Agents; Biomarkers; Blood Pressure; Body Weight; C-Reactive Protein; Cardiovascular Diseases; Female; Humans; Insulin; Kidney Failure, Chronic; Lipids; Lipoprotein(a); Lipoproteins, HDL; Norpregnenes; Pilot Projects; Postmenopause; Renal Dialysis; Risk Factors; Vascular Endothelial Growth Factor A | 2004 |
Does tibolone affect serum leptin levels and body weight in postmenopausal women?
Topics: Adult; Body Weight; Estrogen Receptor Modulators; Female; Humans; Leptin; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies | 2005 |
Apolipoprotein A1 levels in oophorectomized women treated with Org OD 14, oestradiol valerate and a placebo.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Blood Pressure; Body Weight; Castration; Clinical Trials as Topic; Double-Blind Method; Estradiol; Female; Humans; Middle Aged; Norpregnenes | 1984 |
Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies.
Topics: Aged; Body Weight; Bone Density; Double-Blind Method; Endometrium; Female; Humans; Lipids; Middle Aged; Norpregnenes; Osteocalcin; Osteoporosis, Postmenopausal; Uterine Hemorrhage | 2001 |
10 other study(ies) available for tibolone and Body Weight
| Article | Year |
|---|---|
Short-term administration of tibolone reduces inflammation and oxidative stress in the hippocampus of ovariectomized rats fed high-fat and high-fructose.
Topics: Animals; Body Weight; Diet, High-Fat; Female; Fructose; Hippocampus; Hormones; Inflammation; Oxidative Stress; Rats | 2023 |
[Effect of high doses of tibolone in body weight and lipid profile of ovariectomized rats].
Topics: Animals; Body Weight; Cholesterol; Estrogen Receptor Modulators; Female; Norpregnenes; Ovariectomy; Rats; Rats, Wistar; Triglycerides | 2010 |
Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys.
Topics: Animals; Arteriosclerosis; Blood Glucose; Body Composition; Body Weight; C-Peptide; Carbohydrates; Dietary Fats; Energy Intake; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fasting; Female; Fructosamine; Insulin; Insulin Resistance; Macaca fascicularis; Medroxyprogesterone Acetate; Norpregnenes; Ovariectomy; Postmenopause | 2003 |
Effects of tibolone on body composition in postmenopausal women: a 1-year follow up study.
Topics: Absorptiometry, Photon; Body Composition; Body Mass Index; Body Water; Body Weight; Case-Control Studies; Electric Impedance; Estrogen Receptor Modulators; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Postmenopause | 2005 |
Trial of synthetic steroid for preventing postmenopausal osteoporosis.
Topics: Anabolic Agents; Body Weight; Female; Humans; Menopause; Norpregnenes; Osteoporosis | 1980 |
Which form of HRT should we choose?
Topics: Administration, Cutaneous; Administration, Oral; Body Composition; Body Weight; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes | 1998 |
Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomy-induced bone loss in sexually mature rats.
Topics: Anabolic Agents; Animals; Body Weight; Bone Density; Estrogens; Female; Humans; Norpregnenes; Osteoporosis; Ovariectomy; Rats; Rats, Wistar; Sexual Maturation | 1999 |
[Circulating leptin doesn not change in postmenopausal women receiving replacement therapy with tibolone].
Topics: Aged; Body Weight; Estradiol; Estrogen Replacement Therapy; Follicle Stimulating Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Leptin; Luteinizing Hormone; Middle Aged; Norpregnenes; Postmenopause; Prodrugs; Selective Estrogen Receptor Modulators | 2000 |
The influence of tibolone upon serum leptin levels in post-menopausal women.
Topics: Age Factors; Aged; Anabolic Agents; Body Weight; Female; Humans; Leptin; Middle Aged; Norpregnenes; Postmenopause | 2001 |
A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys.
Topics: Animals; Antineoplastic Agents, Hormonal; Apolipoproteins; Arteriosclerosis; Body Weight; Bone Density; Cholesterol, HDL; Coronary Disease; Estradiol; Estrogens; Estrone; Female; Horses; Lipoproteins; Macaca fascicularis; Medroxyprogesterone; Norpregnenes; Postmenopause; Progesterone Congeners | 2001 |